The TRI Human Immune Model Facility (HIMF) establishes availability of humanised preclinical models for Australian research, a capability especially suited to the development and testing of novel therapeutics. Previously only commercially available through the USA or Europe at greater cost and less accessibility, HIMF provides immunodeficient recipient models from The Jackson Laboratory (JAX) that have been transplanted with a human immune system using isolated stem cells.
There is increasing demand globally across academia and industry for innovative preclinical technologies that faithfully recapitulate human immune responses to more reliably and efficiently facilitate informed decision making in preclinical drug development. This facility will enable world class translational research using cutting-edge technology not currently available in the Australian market, along with technical and experimental expertise, support and services to the national research and development community.
The TRI Human Immune Model Facility (HIMF) establishes availability of humanised preclinical models for Australian research, a capability especially suited to the development and testing of novel therapeutics. Previously only commercially available through the USA or Europe at greater cost and less accessibility, HIMF provides immunodeficient recipient models from The Jackson Laboratory (JAX) that have been transplanted with a human immune system using isolated stem cells.
There is increasing demand globally across academia and industry for innovative preclinical technologies that faithfully recapitulate human immune responses to more reliably and efficiently facilitate informed decision making in preclinical drug development. This facility will enable world class translational research using cutting-edge technology not currently available in the Australian market, along with technical and experimental expertise, support and services to the national research and development community.
The HIMF is taking orders now for early 2025. Contact us with expressions of interest.
“Professor Radford and her team have amassed this critical expertise and developed exactly what the Australian research community so urgently need to drive research forward. This visionary program transforms our researchers’ ability to more rapidly and reliably prioritise key research discoveries and take them to the clinic.
Using these types of models, researchers are empowered to move toward clinical trial faster and with increased confidence of success. The establishment of this facility is a game changer. “